Registry of class actions

Overview of the application 500-06-000708-145

Printing of the overview of the application for a class action

Application stage:

Authorization - Application to the Superior Court for authorization to institute a class action

Courthouse:

Montréal

Date of filing of the application for authorization to institute a class action:

2014-09-11

File no.:

500-06-000708-145

Subject:

Protection du consommateur; Protection du consommateur

This case concerns:

Name of parties:

Lebouthillier vs.Janssen Inc. et al.

Description of the class instituting the class action:

All residents of Canada (including their estates, executors, personal representatives, dependants and family members), who purchased and/or ingested and/or were injected with the drugs Risperdal and/or Invega, which drugs were manufactured, marketed or distributed by Respondents and/or related companies, and/or any other Group or Sub-Group to be determined by the Court

Documents and proceedings:

Document Date of document
Application for authorization to institute a class action 2014-09-11
Reply 2014-10-10
Judgment on the stay of an application for authorization to institute a class action 2015-01-07
Other type 2017-12-21

Counsels for the applicant:

Name E-mail Phone Adresse Name of Law Firm Website
Assor, David [email protected] (514)451-5500 4101 Sherbrooke Street West, Westmount, Quebec, Canada , H3Z 1A7 Lex Group Inc. www.lexgroup.ca

Counsels for the defence:

Name E-mail Phone Adresse Name of Law Firm
Torralbo, Robert J. (514)982-4014 600 de Maisonneuve Ouest, suite 2200, Montréal, Quebec, Canada , H3A 3J2 Blake Cassels & Graydon LLP

Application stage

1 - Authorization - Application to the Superior Court for authorization to institute a class action

Courthouse

Montréal

Date of filing of the application for authorization to institute a class action

2014-09-11

File no.

500-06-000708-145

Subject

Protection du consommateur; Protection du consommateur

This case concerns

Name of parties

Lebouthillier vs.Janssen Inc. et al.

All residents of Canada (including their estates, executors, personal representatives, dependants and family members), who purchased and/or ingested and/or were injected with the drugs Risperdal and/or Invega, which drugs were manufactured, marketed or distributed by Respondents and/or related companies, and/or any other Group or Sub-Group to be determined by the Court
Back